SCHEMBL7466503

SCHEMBL7466503

CC(C)(C)OC(=O)N1CC[C@@H](Oc2cncc(-c3cccs3)c2)C1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.50
CHRNB1 P11230 1/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNB3 Q05901 1/20 0.46
USP30 Q70CQ3 1/20 0.45
TGFBR1 P36897 1/20 0.44
PIK3CD O00329 9/20 0.43
PIK3CA P42336 2/20 0.43
PIK3CB P42338 2/20 0.43
PIK3CG P48736 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
CHEK2 O96017 1/20 0.41
GBA1 P04062 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16140302 0.86 GPR119 (0.53) GPR119USP30TGFBR1PIK3CDPIK3CA
SCHEMBL7464202 0.85 USP30 (0.54) GPR119USP30PIK3CDPIK3CAPIK3CB
SCHEMBL7466419 0.83 GPR119 (0.54) GPR119USP30PIK3CDPIK3CAPIK3CB
SCHEMBL7470501 0.81 CHRNB1 (0.57) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL7459146 0.80 USP30 (0.49) GPR119USP30PIK3CDPIK3CAPIK3CB
Hydrochloric Acid SCHEMBL7466311 0.80 CHRNB1 (0.56) CHRNB1CHRNB2CHRNB4CHRNA3CHRNB3
SCHEMBL29686325 0.80 PIK3CD (0.49) GPR119USP30PIK3CDPIK3CAPIK3CB
SCHEMBL7466564 0.80 PIK3CD (0.49) GPR119USP30PIK3CDPIK3CAPIK3CB
SCHEMBL21535643 0.79 PIK3CD (0.48) GPR119USP30PIK3CDPIK3CAPIK3CB
SCHEMBL7463050 0.79 PIK3CD (0.48) GPR119USP30PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151712-A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission LIN NAN-HORNG (US) 2002-10-17 US disclosed
EP-1212319-A2 3-PYRROLIDINYLOXY-3'-PYRIDYL ETHER COMPOUNDS USEFUL FOR CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION Abbott Laboratories (US) 2002-06-12 EP disclosed
WO-2001019817-A2 3-PYRROLIDINYLOXY-3'-PYRIDYL ETHER COMPOUNDS USEFUL FOR CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION ABBOTT LABORATORIES (US) 2001-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151712-A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission GAP43, SLC18A2, GABRE GPR119 604/4885CHRNB1 97/4885CHRNB2 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.